skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 14,080  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Material Type:
Article
Add to My Research

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Annals of oncology, 2015-08, Vol.26 (8), p.1547-1573 [Peer Reviewed Journal]

2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv249 ;PMID: 26026162

Full text available

2
The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
Material Type:
Article
Add to My Research

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate

Annals of oncology, 2021-05, Vol.32 (5), p.579-581 [Peer Reviewed Journal]

2021 ;2021 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. 2021 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2021.01.068 ;PMID: 33582237

Full text available

3
ESMO-Magnitude of Clinical Benefit Scale version 1.1
Material Type:
Article
Add to My Research

ESMO-Magnitude of Clinical Benefit Scale version 1.1

Annals of oncology, 2017-10, Vol.28 (10), p.2340-2366 [Peer Reviewed Journal]

2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx310 ;PMID: 28945867

Full text available

4
Treatment of 95 post-Covid patients with SSRIs
Material Type:
Article
Add to My Research

Treatment of 95 post-Covid patients with SSRIs

Scientific reports, 2023-11, Vol.13 (1), p.18599-18599, Article 18599 [Peer Reviewed Journal]

The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-45072-9 ;PMID: 37919310

Full text available

5
ATR inhibition preferentially targets homologous recombination-deficient tumor cells
Material Type:
Article
Add to My Research

ATR inhibition preferentially targets homologous recombination-deficient tumor cells

Oncogene, 2015-06, Vol.34 (26), p.3474-3481 [Peer Reviewed Journal]

COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jun 25, 2015 ;Macmillan Publishers Limited 2015. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/onc.2014.276 ;PMID: 25174396 ;CODEN: ONCNES

Full text available

6
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Material Type:
Article
Add to My Research

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

Annals of oncology, 2020-10, Vol.31 (10), p.1320-1335 [Peer Reviewed Journal]

2020 European Society for Medical Oncology ;Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. ;2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.07.010 ;PMID: 32745693

Full text available

7
Behavioral Immune Trade-Offs: Interpersonal Value Relaxes Social Pathogen Avoidance
Material Type:
Article
Add to My Research

Behavioral Immune Trade-Offs: Interpersonal Value Relaxes Social Pathogen Avoidance

Psychological science, 2020-10, Vol.31 (10), p.1211-1221 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 0956-7976 ;EISSN: 1467-9280 ;DOI: 10.1177/0956797620960011

Digital Resources/Online E-Resources

8
A large-scale standardized physiological survey reveals functional organization of the mouse visual cortex
Material Type:
Article
Add to My Research

A large-scale standardized physiological survey reveals functional organization of the mouse visual cortex

Nature neuroscience, 2020-01, Vol.23 (1), p.138-151 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2020 ;ISSN: 1097-6256 ;EISSN: 1546-1726 ;DOI: 10.1038/s41593-019-0550-9 ;PMID: 31844315

Full text available

9
Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination
Material Type:
Article
Add to My Research

Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination

Oncogene, 2013-06, Vol.32 (24), p.3001-3008 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jun 13, 2013 ;Macmillan Publishers Limited 2013. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/onc.2012.296 ;PMID: 22797065 ;CODEN: ONCNES

Full text available

10
Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)
Material Type:
Article
Add to My Research

Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)

The Lancet (British edition), 2017-08, Vol.390 (10097), p.871-881 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 26, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31444-7 ;PMID: 28711318

Full text available

11
BMI and lifetime changes in BMI and cancer mortality risk
Material Type:
Article
Add to My Research

BMI and lifetime changes in BMI and cancer mortality risk

PloS one, 2015-04, Vol.10 (4), p.e0125261-e0125261 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Taghizadeh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Taghizadeh et al 2015 Taghizadeh et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0125261 ;PMID: 25881129

Full text available

12
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Material Type:
Article
Add to My Research

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

The lancet oncology, 2017-03, Vol.18 (3), p.e143-e152 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 01, 2017 ;2017. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30074-8 ;PMID: 28271869 ;CODEN: LANCAO

Full text available

13
Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PET
Material Type:
Article
Add to My Research

Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PET

Molecular imaging and biology, 2020-10, Vol.22 (5), p.1218-1225 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 1536-1632 ;EISSN: 1860-2002 ;DOI: 10.1007/s11307-020-01496-7

Digital Resources/Online E-Resources

14
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
Material Type:
Article
Add to My Research

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Annals of oncology, 2016-04, Vol.27 (4), p.619-624 [Peer Reviewed Journal]

2015 European Society for Medical Oncology ;The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdv577 ;PMID: 26598545

Full text available

15
Integrating molecular nuclear imaging in clinical research to improve anticancer therapy
Material Type:
Article
Add to My Research

Integrating molecular nuclear imaging in clinical research to improve anticancer therapy

Nature reviews. Clinical oncology, 2019-04, Vol.16 (4), p.241-255 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2019 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-018-0123-y ;PMID: 30479378

Full text available

16
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)
Material Type:
Article
Add to My Research

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

PloS one, 2014-01, Vol.9 (1), p.e82331 [Peer Reviewed Journal]

COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014 Gaillard et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Gaillard et al 2014 Gaillard et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0082331 ;PMID: 24416140

Full text available

17
Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
Material Type:
Article
Add to My Research

Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques

Nature communications, 2020-12, Vol.11 (1), p.6296-6296, Article 6296 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-20141-z ;PMID: 33293558

Full text available

18
RECIST - learning from the past to build the future
Material Type:
Article
Add to My Research

RECIST - learning from the past to build the future

Nature reviews. Clinical oncology, 2017-03, Vol.14 (3), p.187-192 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Mar 2017 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2016.195 ;PMID: 27995946 ;CODEN: AJHYE6

Full text available

19
Neofunctionalisation of the Sli gene leads to self-compatibility and facilitates precision breeding in potato
Material Type:
Article
Add to My Research

Neofunctionalisation of the Sli gene leads to self-compatibility and facilitates precision breeding in potato

Nature communications, 2021-07, Vol.12 (1), p.4141-4141, Article 4141 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-24267-6 ;PMID: 34230471

Full text available

20
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Material Type:
Article
Add to My Research

Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

The lancet oncology, 2019-08, Vol.20 (8), p.1124-1135 [Peer Reviewed Journal]

Elsevier Ltd ;2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30328-6 ;PMID: 31257177

Full text available

Results 1 - 20 of 14,080  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,133)

Refine My Results

Creation Date 

From To
  1. Before 1958  (508)
  2. 1958 To 1973  (646)
  3. 1974 To 1989  (1,748)
  4. 1990 To 2006  (4,936)
  5. After 2006  (6,244)
  6. More options open sub menu

Language 

  1. English  (12,281)
  2. French  (3,308)
  3. German  (2,598)
  4. Japanese  (725)
  5. Dutch  (336)
  6. Spanish  (292)
  7. Portuguese  (228)
  8. Danish  (120)
  9. Polish  (51)
  10. Swedish  (48)
  11. Russian  (47)
  12. Norwegian  (45)
  13. Italian  (39)
  14. Finnish  (37)
  15. Hungarian  (20)
  16. Czech  (17)
  17. Chinese  (16)
  18. Slovenian  (12)
  19. Turkish  (11)
  20. More options open sub menu

Searching Remote Databases, Please Wait